Active axial spondyloarthritis: potential role of certolizumab pegol
Sriya Ranatunga, Anne V Miller Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, IL, USA Abstract: The axial spondyloarthropathies are a group of chronic inflammatory diseases that predominantly affect the axial joints. This group includes ankylosing sp...
Main Authors: | Ranatunga S, Miller AV |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-02-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/active-axial-spondyloarthritis-potential-role-of-certolizumab-pegol-a15785 |
Similar Items
-
CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-02-01) -
Certolizumab pegol in the treatment of spondyloarthritis
by: Mariusz Korkosz
Published: (2014-09-01) -
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013-07-01) -
Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy
by: Marin J, et al.
Published: (2018-05-01) -
Experience with early use of certolizumab pegol in able-bodied patients with axial spondyloarthritis in the framework of a model for clinical statistical groups
by: Yu. Yu. Grabovetskaya
Published: (2020-09-01)